Details of the Drug Reposition

General Information of This Drug (ID: DMKNRYH)

Drug Name
AKB-9778   DMKNRYH
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Diabetic macular edema DIS162FN 9B71.02 Phase 2 [1]
Peripheral arterial disease DIS78WFB BD4Z Phase 2 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT02387788) Open Label Study to Assess the Efficacy and Safety of AKB-9778 in Subjects With Macular Edema Due to RVO. U.S. National Institutes of Health.